We focus on a number of topic areas identified by state health policy leaders as important to population health.
Keep up with news and updates from the Milbank Memorial Fund. Get the latest from thought leaders, including Christopher F. Koller, president of the Fund.
We publish The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to population health.
The Center for Evidence-based Policy at Oregon Health & Science University is a national leader in evidence-based decision making and policy design.
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
March 1997 (Volume 75)
March 1997 | David M. Lawrence, Patrick H. Mattingly, John M. Ludden
Managed care’s success in improving the health status of communities can be directly attributed to the not-for-profits. Three of the major organizations-Harvard Community Health Plan, Kaiser Permanente, and Group Health Cooperative of Puget Sound-in this category have participated in the critical public policy debates of the past 30 years, have conducted and funded data-based research, and have trained numerous U.S. primary care physicians for practice. An emphasis on health, rather than profits, has led them to favor community rating. Not-for-profits have created an environment that encourages good relationships between patients and professional caregivers. They have discovered that delivering superior care is the most effective way to control costs, and they have done this while fostering partnerships with organized labor. It is critical for the not-for-profits to communicate their obvious advantages to the general public in order to ensure their survival.
Author(s): David M. Lawrence; Patrick H. Mattingly; John M. Ludden
Download the Article
Read on Wiley Online Library
Read on JSTOR
Volume 75, Issue 1 (pages 5–10)
Published in 1997
Determinants of Change in Medicaid Pharmaceutical Cost Sharing: Does Evidence Affect Policy? (pages 11–34)
In This Issue
Get the Latest from the Milbank Memorial Fund